S. 2912Senate115th Congress (2017-2019)In Committee

Opioid Addiction Treatment Programs Enhancement Act

Introduced May 22, 2018

AI-Generated Summary

Updated April 15, 2026 at 9:58 PM UTC

The Opioid Addiction Treatment Programs Enhancement Act directs the U.S. Department of Health and Human Services to create and publish a detailed report on how many Medicaid beneficiaries have substance‑use disorders and what treatment they receive. The report must be posted on the CMS website within a year of the law’s enactment and updated each year through 2024. It also requires the data to be made available to researchers under privacy‑protected rules.

Key Provisions

  • Within 12 months, HHS must release a statewide report using the Transformed Medicaid Statistical Information System (T‑MSIS) that shows numbers and percentages of Medicaid enrollees diagnosed with substance‑use disorders, the types of treatment they receive (counseling, medication‑assisted treatment, etc.), and the settings of that care.
  • The report must break down data by enrollment category, treatment type, payment model (managed care, fee‑for‑service, or alternative), and whether patients move from inpatient/residential care to outpatient or community‑based care.
  • An updated version of the report must be issued each year by January 1, 2024, using data that is no older than 12 months and include notes on data quality and limitations.
  • HHS must publish a Federal Register notice describing how the T‑MSIS data will be shared with researchers, ensuring privacy and security standards, and begin the data‑sharing program by January 1, 2019.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
SenateIntro Referral Latest Action

Read twice and referred to the Committee on Finance.

May 22, 2018

View full timeline
SenateIntro Referral

Introduced in Senate

May 22, 2018

SenateIntro Referral

Read twice and referred to the Committee on Finance.

May 22, 2018

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in SenateIssued May 22, 2018

II

115th CONGRESS

2d Session

S. 2912

IN THE SENATE OF THE UNITED STATES

May 22, 2018

Mr. Cassidy (for himself, Mr. Menendez, Mr. Grassley, and Mr. Warner) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To require the Secretary of Health and Human Services to publish data related to the prevalence of substance use disorders in the Medicaid beneficiary population and the treatment of substance use disorders under Medicaid, and for other purposes.

1.

Short title

This Act may be cited as the Opioid Addiction Treatment Programs Enhancement Act.

2.

T–MSIS substance use disorder data book

(a)

In general

Not later than the date that is 12 months after the date of enactment of this Act, the Secretary of Health and Human Services (in this section referred to as the Secretary) shall publish on the public website of the Centers for Medicare & Medicaid Services a report with comprehensive data on the prevalence of substance use disorders in the Medicaid beneficiary population and services provided for the treatment of substance use disorders under Medicaid.

(b)

Content of report

The report required under subsection (a) shall include, at a minimum, the following data for each State (including, to the extent available, for the District of Columbia, Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa):

(1)

The number and percentage of individuals enrolled in the State Medicaid plan or waiver of such plan in each of the major enrollment categories (as defined in a public letter from the Medicaid and CHIP Payment and Access Commission to the Secretary) who have been diagnosed with a substance use disorder and whether such individuals are enrolled under the State Medicaid plan or a waiver of such plan, including the specific waiver authority under which they are enrolled, to the extent available.

(2)

A list of the substance use disorder treatment services by each major type of service, such as counseling, medication assisted treatment, peer support, residential treatment, and inpatient care, for which beneficiaries in each State received at least 1 service under the State Medicaid plan or a waiver of such plan.

(3)

The number and percentage of individuals with a substance use disorder diagnosis enrolled in the State Medicaid plan or waiver of such plan who received substance use disorder treatment services under such plan or waiver by each major type of service under paragraph (2) within each major setting type, such as outpatient, inpatient, residential, and other home and community-based settings.

(4)

The number of services provided under the State Medicaid plan or waiver of such plan per individual with a substance use disorder diagnosis enrolled in such plan or waiver for each major type of service under paragraph (2).

(5)

The number and percentage of individuals enrolled in the State Medicaid plan or waiver, by major enrollment category, who received substance use disorder treatment through—

(A)

a medicaid managed care entity (as defined in section 1932(a)(1)(B) of the Social Security Act (42 U.S.C. 1396u–2(a)(1)(B))), including the number of such individuals who received such assistance through a prepaid inpatient health plan or a prepaid ambulatory health plan;

(B)

a fee-for-service payment model; or

(C)

an alternative payment model, to the extent available.

(6)

The number and percentage of individuals with a substance use disorder who receive substance use disorder treatment services in an outpatient or home and community-based setting after receiving treatment in an inpatient or residential setting, and the number of services received by such individuals in the outpatient or home and community-based setting.

(c)

Annual updates

The Secretary shall issue an updated version of the report required under subsection (a) not later than January 1 of each calendar year through 2024.

(d)

Use of T–MSIS data

The report required under subsection (a) and updates required under subsection (c) shall—

(1)

use data and definitions from the Transformed Medicaid Statistical Information System (T–MSIS) data set that is no more than 12 months old on the date that the report or update is published; and

(2)

as appropriate, include a description with respect to each State of the quality and completeness of the data and caveats describing the limitations of the data reported to the Secretary by the State that is sufficient to communicate the appropriate uses for the information.

3.

Making T–MSIS data on substance use disorders available to researchers

(a)

In general

The Secretary of Health and Human Services (referred to in this section as the Secretary) shall publish in the Federal Register a system of records notice for the data specified in subsection (b) for the Transformed Medicaid Statistical Information System, in accordance with section 552a(e)(4) of title 5, United States Code. The notice shall outline policies that protect the security and privacy of the data that, at a minimum, meet the security and privacy policies of SORN 09–70–0541 for the Medicaid Statistical Information System.

(b)

Required data

The data covered by the systems of records notice required under subsection (a) shall be sufficient for researchers and States to analyze the prevalence of substance use disorders in the Medicaid beneficiary population and the treatment of substance use disorders under Medicaid across all States (including the District of Columbia, Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa), forms of treatment, and treatment settings.

(c)

Initiation of data-Sharing activities

Not later than January 1, 2019, the Secretary shall initiate the data-sharing activities outlined in the notice required under subsection (a).